drugset / Trial / NCT03441841
Pharmacokinetic Study of Nanoencapsulated Gel of Lidocaine, Prilocaine and Combination of Lidocaine and Prilocaine
Phase 1
Completed
48 enrolled
Galeno Desenvolvimento de Pesquisas Clínicas
Biolab Sanus Farmaceutica · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This trial evaluated the pharmacokinetic interaction between fixed doses of lidocaine (2.5%), prilocaine (2.5%) or the association of both (Nanorap®) in healthy volunteers. The drug safety and tolerability was also evaluated.
Timeline
- Start
- 2016-02-28
- Primary completion
- 2016-03-19
- Completion
- 2016-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 2 g | Topical |
| Comparator | prilocaine | Small molecule | 2 g | Topical |
Indications
No indication recorded.